查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2138203

全球In Silico藥物發現市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global In-Silico Drug Discovery Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 206 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球In Silico藥物發現市場預計將從2025年的43.6億美元成長至2034年的103.4億美元，並預計在2026年至2034年間以10.07%的複合年成長率成長。隨著製藥公司擴大採用電腦輔助方法來加速藥物發現，全球In Silico藥物發現市場正在迅速發展。In Silico輔助技術利用電腦模擬、人工智慧和先進演算法來識別有前景的候選藥物並預測其生物學行為。這種方法可以顯著降低傳統實驗室藥物發現過程所需的時間和成本。

成長要素之一是對更快、更有效率的藥物研發的需求日益成長，尤其是在應對新興疾病和複雜病理方面。製藥和生物技術公司正在將人工智慧 (AI) 和機器學習融入藥物研發流程，以提高準確性和效率。此外，對生物資訊學和計算生物學投入的增加也進一步促進了市場發展。

隨著數位技術不斷變革藥物研發，In Silico藥物發現市場預計將持續成長。巨量資料分析和雲端運算在藥物發現領域的日益普及將提升預測建模能力。醫療保健產業正尋求創新解決方案以加速治療方案的研發，因此，In Silico方法的應用預計將顯著增加。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：我們對主要地理區域的市場表現進行全面審查，以確定高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球In Silico藥物發現市場：按組成部分分類

  • 市場分析、洞察與預測
  • 軟體
  • 服務

第5章：全球In Silico藥物發現市場：依藥物發現階段分類

  • 市場分析、洞察與預測
  • 目標識別與檢驗
  • 命中識別
  • 先導藥物最適化
  • 候選化合物的檢驗

第6章：全球In Silico藥物發現市場：依治療領域分類

  • 市場分析、洞察與預測
  • 腫瘤學
  • 神經病學
  • 心血管系統
  • 感染疾病
  • 代謝性疾病

第7章：全球In Silico藥物發現市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 製藥公司
  • 生技公司
  • 學術研究機構
  • CRO

第8章：全球In Silico藥物發現市場：依研發階段分類

  • 市場分析、洞察與預測
  • 現場
  • 基於雲端的

第9章 全球In Silico藥物發現市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • SchrodingerInc
    • Exscientia Plc
    • Recursion PharmaceuticalsInc
    • Insilico Medicine
    • BenevolentAI
    • AtomwiseInc
    • Relay TherapeuticsInc
    • XtalPi Inc
    • Cyclica Inc
    • Valence Discovery
    • Isomorphic Labs
    • Owkin
    • NVIDIA Corporation
    • IBM Corporation
    • Microsoft Corporation
    • Google DeepMind
    • CertaraInc
    • Dassault Systemes SE
    • Crown Bioscience
    • Evotec SE
簡介目錄
Product Code: VMR112114720

The global in-silico drug discovery market size is expected to reach USD 10.34 Billion in 2034 from USD 4.36 Billion in 2025, growing at a CAGR of 10.07% during 2026-2034.The Global In-Silico Drug Discovery Market is rapidly gaining momentum as pharmaceutical companies increasingly adopt computational methods to accelerate drug development. In-silico technologies use computer simulations, artificial intelligence, and advanced algorithms to identify potential drug candidates and predict their biological behavior. This approach significantly reduces the time and cost associated with traditional laboratory-based drug discovery processes.

One of the major growth drivers is the rising demand for faster and more efficient drug development, particularly in response to emerging diseases and complex medical conditions. Pharmaceutical and biotechnology companies are integrating artificial intelligence and machine learning into drug discovery workflows to enhance accuracy and efficiency. Additionally, increasing investments in bioinformatics and computational biology are further strengthening the market.

Looking ahead, the in-silico drug discovery market is expected to expand as digital technologies continue to transform pharmaceutical research. The growing use of big data analytics and cloud computing in drug development will enhance predictive modeling capabilities. As the healthcare industry seeks innovative solutions to accelerate therapeutic discoveries, the adoption of in-silico methods is likely to increase significantly.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Component

  • Software
  • Services

By Drug-Discovery Phase

  • Target Identification & Validation
  • Hit Identification
  • Lead Optimization
  • Candidate Validation

By Therapeutic Area

  • Oncology
  • Neurology
  • Cardiovascular
  • Infectious Diseases
  • Metabolic Disorders

By End User

  • Pharmaceutical Companies
  • Biotechnology Firms
  • Academic & Research Institutes
  • CROs

By Deployment

  • On-premise
  • Cloud-based

COMPANIES PROFILED

  • Schrodinger, Inc., Exscientia plc, Recursion Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Atomwise, Inc., Relay Therapeutics, Inc., XtalPi Inc., Cyclica Inc., Valence Discovery, Isomorphic Labs, Owkin, NVIDIA Corporation, IBM Corporation, Microsoft Corporation, Google DeepMind, Certara, Inc., Dassault Systemes SE, Crown Bioscience, Evotec SE

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Component
  • 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY DRUG-DISCOVERY PHASE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Drug-discovery Phase
  • 5.2. Target Identification & Validation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Hit Identification Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Lead Optimization Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Candidate Validation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Therapeutic Area
  • 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Cardiovascular Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Metabolic Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Biotechnology Firms Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY DEPLOYMENT 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Deployment
  • 8.2. On-premise Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Cloud-based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Component
    • 9.2.2 By Drug-discovery Phase
    • 9.2.3 By Therapeutic Area
    • 9.2.4 By End User
    • 9.2.5 By Deployment
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Component
    • 9.3.2 By Drug-discovery Phase
    • 9.3.3 By Therapeutic Area
    • 9.3.4 By End User
    • 9.3.5 By Deployment
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Spain
    • 9.3.11 Russia
    • 9.3.12 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Component
    • 9.4.2 By Drug-discovery Phase
    • 9.4.3 By Therapeutic Area
    • 9.4.4 By End User
    • 9.4.5 By Deployment
    • 9.4.6 China
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 India
    • 9.4.10 Australia
    • 9.4.11 South East Asia
    • 9.4.12 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Component
    • 9.5.2 By Drug-discovery Phase
    • 9.5.3 By Therapeutic Area
    • 9.5.4 By End User
    • 9.5.5 By Deployment
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Component
    • 9.6.2 By Drug-discovery Phase
    • 9.6.3 By Therapeutic Area
    • 9.6.4 By End User
    • 9.6.5 By Deployment
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL IN-SILICO DRUG DISCOVERY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 SchrodingerInc
    • 11.2.2 Exscientia Plc
    • 11.2.3 Recursion PharmaceuticalsInc
    • 11.2.4 Insilico Medicine
    • 11.2.5 BenevolentAI
    • 11.2.6 AtomwiseInc
    • 11.2.7 Relay TherapeuticsInc
    • 11.2.8 XtalPi Inc
    • 11.2.9 Cyclica Inc
    • 11.2.10 Valence Discovery
    • 11.2.11 Isomorphic Labs
    • 11.2.12 Owkin
    • 11.2.13 NVIDIA Corporation
    • 11.2.14 IBM Corporation
    • 11.2.15 Microsoft Corporation
    • 11.2.16 Google DeepMind
    • 11.2.17 CertaraInc
    • 11.2.18 Dassault Systemes SE
    • 11.2.19 Crown Bioscience
    • 11.2.20 Evotec SE